Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device
Key facts
- Where
- Albany, Baltimore, Boston, Buffalo, Columbus, Durham, Hollywood, Honolulu, Iowa City, Kansas City, Lexington, Louisville, Manhasset, Memphis, Minneapolis, Morgantown, Oklahoma City, Orlando, Philadelphia, Shreveport, St Louis, Stony Brook, The Bronx, Toledo, and Worcester, United StatesSee the 29 sites
Where in United States
- Albany Medical CenterAlbany, United StatesContact: Julia ZajaceskowskiTaking people
- Johns Hopkins UniversityBaltimore, United StatesContact: Rachael EddowesTaking people
- University of Maryland, BaltimoreBaltimore, United StatesContact: Robert GashNo longer taking part
- Massachusetts General Brigham IncorporatedBoston, United StatesContact: Shayna HollanderTaking people
- University of BuffaloBuffalo, United StatesContact: Eric MillerTaking people
- Ohio State UniversityColumbus, United StatesContact: Edouard BelizaireTaking people
- OhioHealth Research InstituteColumbus, United StatesContact: Marissa MosherTaking people
- Duke UniversityDurham, United StatesContact: Robert GashNo longer taking part
- Memorial Health SystemsHollywood, United StatesContact: Piret BaldwinTaking people
- The Queen's Medical Center Neuroscience InstituteHonolulu, United StatesContact: Kelly DiedrichTaking people
- University of Iowa Hospitals and ClinicsIowa City, United StatesContact: Heena OlaldeTaking people
- University of Kansas Health SystemKansas City, United StatesContact: Max HardenbrookTaking people
- Baptist Health SystemsLexington, United StatesContact: Candice BruntonTaking people
- University of Kentucky, Department of NeurosurgeryLexington, United StatesContact: Rachel NorrisTaking people
- Norton HealthcareLouisville, United StatesContact: Trina DeForrestTaking people
- Northshore University Hospital/Northwell HealthManhasset, United StatesContact: Stanislav OstrovskiTaking people
- Semmes MurpheyMemphis, United StatesContact: Amira KingTaking people
- Abbott Northwestern Hospital Allina HealthMinneapolis, United StatesContact: Nimco EssaTaking people
- West Virginia UniversityMorgantown, United StatesContact: Jennifer DomicoTaking people
- University of Oklahoma Health Sciences CenterOklahoma City, United StatesContact: Michael OminiTaking people
- Orlando Health Neuroscience InstituteOrlando, United StatesContact: Thomas MelendezTaking people
- Thomas Jefferson University HospitalPhiladelphia, United StatesContact: Sha'Mere HerderTaking people
- University of Pennsylvania Health SystemsPhiladelphia, United StatesContact: Inhye HwangTaking people
- LSU Health Sciences Center at ShreveportShreveport, United StatesContact: Annabeth PiroTaking people
- The Washington UniversitySt Louis, United StatesContact: Ramie HeoTaking people
- SUNY-Stony BrookStony Brook, United StatesContact: Dawn MadiganTaking people
- Montefiore Medical CenterThe Bronx, United StatesContact: Lavinia WilliamsTaking people
- The Toledo Hospital d/b/a ProMedica Toledo HospitalToledo, United StatesContact: Jennifer DuraTaking people
- UMASS Memorial HealthWorcester, United StatesContact: Noelle BodkinTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Microvention-Terumo, Inc.
- Trial code
- NCT04839705
- Record updated
- 10 November 2026
- Original description
A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequate intracranial aneurysm occlusion on the 1 year angiogram as adjudicated by a core laboratory.Read full original descriptionShow less
Post-Approval Study - Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the WEB Device
A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequate intracranial aneurysm occlusion on the 1 year angiogram as adjudicated by a core laboratory.
Inclusion: Patient must be ≥ 18 at the time of screening; Patient must have a single ruptured or unruptured IA requiring treatment; Patient must sign and date an IRB-approved written informed consent prior to initiation of any study procedures.
Exclusion: Patient has conditions placing them at high risk for ischemic stroke or has exhibited ischemic symptoms such as transient ischemic attacks, minor strokes, or stroke-in-evolution within the prior 30 days; Patient's index IA was previously treated; Patient has had an SAH from a non-index IA or any other intracranial hemorrhage within 90 days; Patient has an IA with characteristics unsuitable for endovascular treatment; Patient is pregnant.